Primary Record
difluprednate
- In stock
- 1,605 g
- Purity
- 98.3 %
- CAS
- 23674-86-4
Compound Identifiers & Properties
- CAS
- 23674-86-4
- PubChem CID
- 443936
- SMILES
- CCCC(=O)O[C@@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C(=O)COC(=O)C
- Canonical SMILES
- CCCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
Names & Synonyms
- difluprednate
- Durezol
- Difluprednato
- Epitopic
- DFBA
- Difluprednatum
- Myser
- 23674-86-4
- Plapasta
- Sifunarl
- Trihomon
- Flunert
- Naltarl
- Saivase
- Solomy
- Durezol (TN)
- S8A06QG2QE
- Difluprednate Ophthalmic
- RefChem:58678
- UNII-S8A06QG2QE
- Difluprednate (Standard)
- AC1L9FFL
- Difluprednatum [INN-Latin]
- Opera_ID_1287
- Difluprednato [INN-Spanish]
- DIFLUPREDNATE [MI]
- DTXSID0046773
- D01ZOG
- DIFLUPREDNATE [INN]
- DIFLUPREDNATE [JAN]
- Difluoroprednisolone butyrate acetate
- MLS000028663
- SCHEMBL4580
- C27H34F2O7
- DIFLUPREDNATE [USAN]
- Difluprednate [USAN:INN:JAN]
- DIFLUPREDNATE [VANDF]
- DTXCID8026773
- MLS001148580
- MLS001333701
- st60-1
- DIFLUPREDNATE [MART.]
- CM 9155
- DIFLUPREDNATE [WHO-DD]
- MFCD00214273
- GTPL7474
- orb1300739
- orb3025661
- CHEMBL1201749
- Difluprednate (JAN/USAN/INN)
- CHEBI:31485
- Difluprednate Ophthalmic Emulsion
- EINECS 245-815-4
- D07AC19
- WYQPLTPSGFELIB-JTQPXKBDSA-N
- GLXC-20123
- HMS2231D18
- W 6309
- W-6309
- DIFLUPREDNATE [ORANGE BOOK]
- ACT03289
- ZINC4212945
- Tox21_112628
- CID443936
- EBC-27253
- HY-17569R
- MSK011014
- s4095
- SMR000058924
- AKOS027326853
- C27-H34-F2-O7
- CCG-269762
- CM-9155
- CS-3001
- DB06781
- FD21894
- MSK011014-100A
- 6a,9-Difluoro-11b,17,21-trihydroxyp
- MSK011014-1000A
- NCGC00168749-01
- AS-15800
- DA-52531
- HY-17569
- J15.820H
- Q827
- SC-18767
- SY234728
- AB2000742
- CAS-23674-86-4
- B1728
- D5579
- FT-0650192
- NS00050777
- [(6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate
- C12695
- D01266
- 6-alpha,9-alpha-Difluoroprednisolone 17-butyrate 21-acetate
- AB00383058_10
- EN300-7378069
- 674D864
- A932746
- Difluprednate Solution in Acetonitrile, 1000ug/mL
- Difluprednate Solution in Acetonitrile, 100ug/mL
- Q736113
- SR-01000000265
- (6alpha,11beta)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dion
- SR-01000000265-4
- 3-Amino-2-(methylamino)-5-(trifluoromethyl)pyridine
- 6|A,9|A-Difluoroprednisolone 21-acetate 17-butyrate
- 6alpha,9alpha-Difluorprednisolon-17-butyrat-21-acetat
- 6alpha-9-Difluoroprednisolone 21-acetate 17-butyrate
- 6 alpha-9-difluoroprednisolone 21-acetate 17-butyrate
- 6alpha,9-Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate
- 21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione (6alpha,11beta)-
- 6 alpha ,9 alpha -Difluoroprednisolone 21-acetate 17-butyrate
- 6ALPHA,9ALPHA-DIFLUOROPREDNISOLONE 21-ACETATE 17-BUTYRATE
- 6alpha,9alpha-Difluoroprednisolone 21-acetate 17-butyrate, >=98%
- (1R,3aS,3bS,5S,9aS,9bR,10S,11aS)-1-[2-(acetyloxy)acetyl]-5,9b-difluoro-10-hydroxy-9a,11a-dimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl butanoate
- (6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetoxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl butyrate
- Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6.alpha.,11.beta.)-
- Pregna-1,4-diene-3,20-dione, 6-alpha,9-difluoro-11-beta,17,21-trihydroxy-, 21-acetate, 17-butyrate
- "MLS001148580-01!6ALPHA,9ALPHA-DIFLUOROPREDNISOLONE 21-ACETATE 17-BUTYRATE"
- 21-(Acetyloxy)-6alpha,9-difluoro-11beta-hydroxy-3,20-dioxopregna-1,4-dien-17-yl butanoate
- 21-Acetyloxy-6alpha,9-difluoro-11beta-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
- ((6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetyloxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) butanoate
- (1R,2S,8S,10S,11S,14R,15S,17S)-14-(2-(acetyloxy)acetyl)-1,8-difluoro-17-hydroxy-2,15-dimethyl-5-oxotetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-14-yl butanoate
- (1R,2S,8S,10S,11S,14R,15S,17S)-14-[2-(acetyloxy)acetyl]-1,8-difluoro-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl butanoate
- (6-alpha,11-beta)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dione
- (6|A,11|A)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dion
- (6a,11b)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione
- (6a,11beta)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)pregna-1,4-diene-3,20-dion
- [(6S,8S,9R,10S,11S,13S,14S,17R)-17-(2-acetoxyacetyl)-6,9-difluoro-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] butanoate
- 245-815-4
- 6-alpha,9-difluoro-11-beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate
- CM 9155; Difluprednate; Durezol; Epitopic; Myser; W 6309; (6alpha,11beta)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-pregna-1,4-diene-3,20-dione; Pregna-1,4-diene-3,20-dione, 6alpha,9-difluoro-11beta,17,21-trihydroxy-, 21-acetate 17-butyrate (8CI); Butyric acid, 17-ester with 6alpha,9-difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate (8CI); 6a,9-Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate 17-butyrate; 6alpha,9-Difluoroprednisolone 21-acetate 17-butyrate; 6alpha,9alpha-Difluoroprednisolone 21-acetate 17-butyrate
- Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6alpha,11beta)-
- Pregna-1,4-diene-3,20-dione, 6.alpha.,9-difluoro-11.beta.,17,21-trihydroxy-, 21-acetate 17-butyrate
- Pregna-1,4-diene-3,20-dione,21-(acetyloxy)-6,9-difluoro-11-hydroxy-17-(1-oxobutoxy)-, (6a,11b)-